Technology
New On Robinhood
Health

Turning Point Therapeutics

$42.36
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-0.31%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell TPTX and other stocks, options, ETFs, and crypto commission-free!

About

Turning Point Therapeutics, Inc. engages in the discovery and development of precision medicines for cancer and other diseases. It focuses on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity. Read More The company was founded by J. Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.

Employees
50
Headquarters
San Diego, California
Founded
2013
Market Cap
1.33B
Price-Earnings Ratio
Dividend Yield
Average Volume
272.94K
High Today
$42.96
Low Today
$41.03
Open Price
$42.78
Volume
135.99K
52 Week High
$47.72
52 Week Low
$24.21

Collections

Technology
New On Robinhood
Health
Pharmaceutical
Therapy
Cancer Prevention
Medical
2019 IPO
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.